Fazirsiran Injection
TAK-999-3002
Phase 3 small_molecule active
Quick answer
Fazirsiran Injection for Alpha1-Antitrypsin Deficiency is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Alpha1-Antitrypsin Deficiency
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active